Science and Technology Program of Guangzhou,No.202102010077;International Science Foundation of Guangzhou Fuda Cancer Hospital,No.Y2020-ZD-03.
BACKGROUND Irreversible electroporation(IRE)is a novel local tumor ablation approach with the potential to activate the host’s immune system.However,this approach is insufficient to prevent cancer progression,and com...
the NIH for support of this research(P41EB028239);the National Science Foundation Graduate Research Fellowship(Nos.DGE-1746891(SEW)and DGE-1746891(SRS)).
Adoptive cell therapy(ACT)is an immunotherapy strategy for cancer that has seen widespread clinical success.During ACT,patient-derived lymphocytes are stimulated with the antigen of interest ex vivo,proliferated,then ...
supported by the National Natural Science Foundation of China(No.81972681,82103677);Tianjin Education Commission Research Plan Project(No.2021KJ201);Shenzhen High-level Hospital Construction Fund(No.G2022139);Tianjin Key Medical Discipline(Specialty)Construction Project(No.TJYXZDXK-009A).
Objective:CD8+T cells are the key effector cells in the anti-tumor immune response.The mechanism underlying the infiltration of CD8+T cells in esophageal squamous cell carcinoma(ESCC)has not been clearly elucidated.Me...
CAMS Innovation Fund for Medical Sciences(CIFMS)(2021-I2M-1-061 and 2021-1-I2M-003);CSCO-hengrui Cancer Research Fund(Y-HR2019-0239);CSCO-MSD Cancer Research Fund(Y-MSDZD2021-0213);National Ten-thousand Talent Program(to J.L.);Young Scientists Fund of the National Natural Science Foundation of China(82303720);Beijing Natural Science Foundation(7234381);Fundamental Research Funds for the Central Universities(3332023011 to J.L.).
Background:Hepatocholangiocarcinoma(H-ChC)has the clinicopathological features of both hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(iCCA)and is a more aggressive subtype of primary hepatic carcinom...
supported by Joint Funds for the Innovation of Science and Technology,Fujian Province[Grant number:2020Y9039];Fujian Provincial Health Technology Project[Grant number:2022GGA032].
Objective Triple-negative breast cancer(TNBC)poses a significant challenge for treatment efficacy.CD8+T cells,which are pivotal immune cells,can be effectively analyzed for differential gene expression across diverse ...